Filing Flows

Filing Flows › Zimmer Biomet Holdings (ZBH) › Q2 2025

Zimmer Biomet Holdings (ZBH) Q2 2025 earnings results (second quarter 2025)

10-Q filed Aug 7, 2025

Zimmer Biomet Holdings (ZBH) reported revenue of $2.1B for the second quarter 2025 (Q2 2025), +7% from a year earlier and +9% from the quarter before. Operating margin was 14.4%, net earnings $153M (7.4% of revenue).

Revenue$2.1B
Year over year+7%
Quarter over quarter+9%
Operating margin14.4%
Net earnings$153M

Zimmer Biomet Holdings, Q2 2025: revenue $2.1B (+7% year over year), operating margin 14.4%, net earnings $153M, operating cash flow $378M. The chart follows the revenue to costs, profit and cash.

Q2 2025AmountQ/QY/Y
Revenue$2.1B+9%+7%
Operating profit$300M+3%-15%
Net earnings$153M-16%-37%
Operating cash flow$378M-1%+2%
Free cash flow$248M—-2%

What changed

Revenue was $2.1B in Q2 2025, up 7% year over year and up 9% from the previous quarter. Knees was the largest line at 40% of revenue. SET added $0.08B year over year (up 17%), 60% of the total change.

Operating profit was $0.30B, a 14.4% margin (down 3.6 points year over year). Operating profit fell $0.05B even though revenue rose $0.14B versus a year earlier, so costs grew faster than sales. Total costs grew 12% against revenue growth of 7%. The fastest-growing cost line was Other operating costs (+35%). Net earnings were $0.15B, down 37% year over year. The effective tax rate was 31.7%.

Operating cash flow was $0.38B (up 2% year over year), 247% of net earnings. Non-cash charges added back $0.27B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.07B. After itions to instruments ($0.08B) and itions to other property, plant and equipment ($0.05B), free cash flow as the company reports it was $0.25B.

Questions

What was Zimmer Biomet Holdings' revenue in the second quarter 2025?

Zimmer Biomet Holdings (ZBH) reported revenue of $2.1B for the second quarter 2025 (Q2 2025), +7% from a year earlier and +9% from the quarter before.

Was Zimmer Biomet Holdings profitable in the second quarter 2025?

Operating profit was $300M (14.4% of revenue) and net earnings $153M.

Open the interactive Sankey →

Source: Zimmer Biomet Holdings 10-Q on SEC EDGAR.